About Augustine Therapeutics
Augustine Therapeutics is a public limited company (NV/SA) based in Leuven, founded in 2019. Its main activity is classified as "Speur- en ontwikkelingswerk op biotechnologisch gebied". For the 2025 financial year, Augustine Therapeutics reported a loss of €14.8 million. That makes 6 loss-making financial years in a row for Augustine Therapeutics. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€1.7 million. It employed an average of 12 full-time equivalents. Equity stands at €29 million, a solvency ratio of 94%. In 2020 it was €1.7 million. 6 annual accounts are available, covering 2020 to 2025.
- Signals
-
Reporting lossesReporting losses € -14.79M
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -2.32MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -3.21MEBITDA is negative: operating activities are loss-making.
High social debt vs. personnel costsHigh social debt vs. personnel costs 25.2%Social debts are a high share of personnel costs, which may indicate social security arrears.
Strong equityStrong equity € 28.98MStrong equity provides a buffer against setbacks.
Low riskLow risk 93.8%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 16.43A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-1.66M
|
€
-1.74M
|
€
-516K
|
€
-1.99M
|
|
|
€
-3.21M
|
€
-2.55M
|
€
-930K
|
€
-2.23M
|
|
|
€
-14.79M
|
€
-8.56M
|
€
-4.16M
|
€
-3.13M
|
|
|
€
28.98M
|
€
6.77M
|
€
-2.19M
|
€
1.97M
|
|
|
93.76%
|
76.74%
|
-41.22%
|
72.91%
|
|
|
€
1.93M
|
€
2.05M
|
€
7.49M
|
€
733K
|
|
|
€
27.16M
|
€
7.75M
|
€
3.81M
|
€
1.58M
|
|
|
12
|
7
|
5
|
2
|
Publications 17
All publications- Diversen - Ontslagen - Benoemingen 17/06/2025
- Ontslagen - Benoemingen 21/05/2025
- Statuten (Vertaling, Co?Rdinatie, Overige Wijzigingen, ?) - Kapitaal - Aandelen - Ontslagen - Benoemingen 01/07/2024
- Ontslagen - Benoemingen 29/11/2023
- Ontslagen - Benoemingen 20/10/2023
Frequently asked questions
Answers to the most common questions about Augustine Therapeutics, based on official government data and the filed annual accounts.
What is the VAT number of Augustine Therapeutics?
The VAT number of Augustine Therapeutics is BE0722.705.230.
How many employees work at Augustine Therapeutics?
In 2025, Augustine Therapeutics employed 12.00 full-time equivalents (FTE).
When was Augustine Therapeutics established?
Augustine Therapeutics was founded in 13-03-2019.
What is the official address of Augustine Therapeutics?
The official address of Augustine Therapeutics is Gaston Geenslaan 3 Leuven 3001.
What is the legal form of Augustine Therapeutics?
The juridical form of Augustine Therapeutics is Public limited company (NV/SA).
What is the annual revenue of Augustine Therapeutics?
The 2025 accounts of Augustine Therapeutics do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Augustine Therapeutics a reliable company?
Augustine Therapeutics is a registered Rechtspersoon with company number 0722.705.230 and can be verified through the official CBE database.
What is the credit limit of Augustine Therapeutics?
The estimated credit limit of Augustine Therapeutics is €1,412,731.
Is Augustine Therapeutics still active?
Augustine Therapeutics currently has the status "Normal situation" and is active.